Literature DB >> 21949045

Parenteral peramivir treatment for Oseltamivir-resistant 2009 pandemic influenza A H1N1 viruses.

Yacine Abed, Guy Boivin, Ryu Yoshida, Makoto Kodama, Jaime E Hernandez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21949045     DOI： 10.1093/infdis/jir610

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

1.  Combining molecular docking and molecular dynamics to predict the binding modes of flavonoid derivatives with the neuraminidase of the 2009 H1N1 influenza A virus.

Authors:  Shih-Jen Lu; Fok-Ching Chong
Journal:  Int J Mol Sci       Date:  2012-04-10       Impact factor: 6.208

Review 2.  Safety and efficacy of peramivir for influenza treatment.

Authors:  Atsuko Hata; Ryoko Akashi-Ueda; Kazufumi Takamatsu; Takuro Matsumura
Journal:  Drug Des Devel Ther       Date:  2014-10-24       Impact factor: 4.162

3.  Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.

Authors:  A C Hurt; K Hardie; N J Wilson; Y M Deng; M Osbourn; S K Leang; R T C Lee; P Iannello; N Gehrig; R Shaw; P Wark; N Caldwell; R C Givney; L Xue; S Maurer-Stroh; D E Dwyer; B Wang; D W Smith; A Levy; R Booy; R Dixit; T Merritt; A Kelso; C Dalton; D Durrheim; I G Barr
Journal:  J Infect Dis       Date:  2012-05-04       Impact factor: 5.226

Review 4.  Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections.

Authors:  Malak M Alame; Elie Massaad; Hassan Zaraket
Journal:  Front Microbiol       Date:  2016-03-31       Impact factor: 5.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.